Science Explorer Back to mapMap
Discussion
Researcher · Lourdes Hospital · United States

Patrick R. Bergevin

Patrick R. Bergevin publishes mostly in Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Cancer Treatment and Pharmacology, Cancer therapeutics and mechanisms and Chemotherapy-induced cardiotoxicity and mitigation.

OpenAlex
World rank
#3,887,920
of 7,710,434 ranked researchers
Rank in United States
#1,066,430
of 1,627,098
Works
22
Citations
438
Citations per work
19.9
h-index
6
i10-index 4Top 84% in Oncology
Patrick R. Bergevin

What does Patrick R. Bergevin research?

Patrick R. Bergevin's work is mostly in Medicine (29%), Biochemistry, Genetics and Molecular Biology (12%), Immunology and Microbiology (5%).

Everything else: 12 works · 53.4% of their workHealth Sciences: 6 works · 28.7% of their workMedicine: 6 works · 28.7% of their workOncology: 3 works · 12.5% of their workGenetics: 1 works · 5.4% of their workNeurology: 1 works · 5.4% of their workPulmonary and Respiratory Medicine: 1 works · 5.4% of their workLife Sciences: 4 works · 17.9% of their workBiochemistry, Genetics and Molecular Biology: 3 works · 12.5% of their workMolecular Biology: 3 works · 12.5% of their workImmunology and Microbiology: 1 works · 5.4% of their workImmunology: 1 works · 5.4% of their workTHEIR WORKPatrick R.Bergevin22works
Life Sciences18%Health Sciences29%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1253.4%
    1. Medicine628.7%
    1. Biochemistry, Genetics and Molecular Biology312.5%
    2. Immunology and Microbiology15.4%
  1. 1Oncology12% of their works
  2. 2Molecular Biology12% of their works
  3. 3Pulmonary and Respiratory Medicine5% of their works
  4. 4Neurology5% of their works
  5. 5Immunology5% of their works
  6. 6Genetics5% of their works

Research topics

Which keywords describe Patrick R. Bergevin's research?

The keywords of their largest research topics: Chemotherapy-Induced Peripheral Neuropathy, Taxanes, Chemotherapy, Immunotherapy, DNA, Topoisomerases, Anthracyclines and Brain Metastases.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Chemotherapy-Induced Peripheral Neuropathy71 topic
  2. Taxanes71 topic
  3. Chemotherapy52 topics
  4. Immunotherapy42 topics
  5. DNA31 topic
  6. Topoisomerases31 topic
  7. Anthracyclines21 topic
  8. Brain Metastases21 topic
  9. Cancer22 topics
  10. Doxorubicin21 topic
  11. Glioblastoma21 topic
  12. Radiosurgery21 topic
  13. Temozolomide21 topic
  14. Biosynthesis11 topic
  15. Glycans11 topic
  16. Glycosylation11 topic
  17. Lignans11 topic
  18. Signaling11 topic
  19. mTOR11 topic

Where does Patrick R. Bergevin work?

Patrick R. Bergevin's main affiliation in the publication record is Lourdes Hospital, United States.

How many publications and citations does Patrick R. Bergevin have?

OpenAlex counts 22 works and 438 citations for Patrick R. Bergevin, an h-index of 6, ranking #3,887,920 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Patrick R. Bergevin. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.